Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Mitsuhisa Nishimoto"'
Autor:
Ken Fukiage, Kazutoshi Fujita, Shingo Toyoda, Mitsuhisa Nishimoto, Takashi Kikuchi, Takaaki Chikugo, Kazuhiro Yoshimura, Atsunobu Esa, Akihiko Ito, Hirotsugu Uemura
Publikováno v:
IJU Case Reports, Vol 7, Iss 2, Pp 141-143 (2024)
Introduction Inflammatory myofibroblastic tumors are borderline malignant soft tissue tumors primarily affecting the lungs and pelvic organs. This report presents a rare case of an inflammatory myofibroblastic tumor originating from the prostate glan
Externí odkaz:
https://doaj.org/article/ef0e6d57dd314964b1615be5a20d88f8
Autor:
Saizo Fujmoto, Kazutoshi Fujita, Mitsuhisa Nishimoto, Mamoru Hamaguchi, Ken Kuwahara, Mamoru Hashimoto, Shogo Adomi, Takafumi Minami, Masahiro Nozawa, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3176-3179 (2023)
Abstract Enzalutamide, apalutamide, and darolutamide are currently recommended for patients with non‐metastatic castration‐resistant prostate cancer (nmCRPC), but cross‐resistance of androgen receptor‐axis‐targeted therapies (ARAT) occurs.
Externí odkaz:
https://doaj.org/article/f9ff1f67dce24f7fabefde0baaee780d
Autor:
Makoto Matsushita, Kazutoshi Fujita, Daisuke Motooka, Koji Hatano, Junya Hata, Mitsuhisa Nishimoto, Eri Banno, Kentaro Takezawa, Shinichiro Fukuhara, Hiroshi Kiuchi, Yue Pan, Toshifumi Takao, Akira Tsujimura, Shinichi Yachida, Shota Nakamura, Wataru Obara, Hirotsugu Uemura, Norio Nonomura
Publikováno v:
The World Journal of Men's Health, Vol 40, Iss 3, Pp 517-525 (2022)
Purpose: In males, testosterone levels have been implicated in various diseases. Recently, the influence of gut microbial-derived compounds on host metabolism has become evident, and it has been suggested that some gut bacteria may be in-volved in te
Externí odkaz:
https://doaj.org/article/fa5a8959cd8d45aab0b39697d4042522
Autor:
Naoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, Yutaka Yamamoto, Ken Kuwahara, Yasuharu Nagai, Takafumi Minami, Yuji Hatanaka, Masahiro Nozawa, Yasuhiro Morimoto, Hideo Tahara, Shigeya Uejima, Atsunobu Esa, Akihide Hirayama, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
This study aimed to compare the effects of abiraterone acetate plus prednisone (AAP) with androgen deprivation therapy (ADT) with those of combined androgen blockade (CAB) therapy in patients with high-risk metastatic hormone-sensitive prostate cance
Externí odkaz:
https://doaj.org/article/f92ba2e2dfeb49a58807315bbf859ffa
Autor:
MITSUHISA NISHIMOTO, KAZUTOSHI FUJITA, ARITOSHI RI, SAIZO FUJIMOTO, YASUO OGUMA, SHINGO TOYODA, MAMORU HASHIMOTO, TAKASHI KIKUCHI, SHOGO ADOMI, YOSHITAKA SAITO, YASUNORI MORI, TAKAFUMI MINAMI, MASAHIRO NOZAWA, KAZUHIRO YOSHIMURA, MAKOTO HOSONO, HIROTSUGU UEMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Jul/Aug2024, Vol. 4 Issue 4, p441-446, 6p
Autor:
Takafumi Minami, Kazutoshi Fujita, Mamoru Hashimoto, Mitsuhisa Nishimoto, Shogo Adomi, Eri Banno, Masahiro Nozawa, Kazuhiro Nose, Kazuhiro Yoshimura, Masahiro Inada, Masaki Yokokawa, Kiyoshi Nakamatsu, Hirotsugu Uemura
Publikováno v:
World Journal of Urology. 41:1317-1321
Autor:
Mamoru Hashimoto, Nobutaka Shimizu, Saizo Fujimoto, Ken Kuwahara, Mitsuhisa Nishimoto, Shogo Adomi, Eri Banno, Takafumi Minami, Kazutoshi Fujita, Kazuhiro Yoshimura, Akihide Hirayama, Hirotsugu Uemura
Publikováno v:
International Urology and Nephrology. 55:69-74
In this study, we aimed to elucidate the pathophysiology of post-micturition dribble (PMD) through analyzing several variables including pressure flow study (PFS) findings and symptoms questionnaire.We retrospectively analyzed male patients who visit
Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer
Autor:
Mitsuhisa Nishimoto, Kazutoshi Fujita, Yutaka Yamamoto, Mamoru Hashimoto, Shogo Adomi, Eri Banno, Yoshitaka Saito, Nobutaka Shimizu, Yasunori Mori, Takafumi Minami, Masahiro Nozawa, Kazuhiro Nose, Akihide Hirayama, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
Translational Cancer Research. 11:2681-2687
Several therapeutic agents are available for metastatic castration-resistant prostate cancer (CRPC). However, prognosis is still not well developed. The Gleason score (GS) is a prognostic factor available for patients with metastatic CRPC. GSs rangin
Autor:
Takahito Nakayama, Nobutaka Shimizu, Marco A. De Velasco, Eri Banno, Shogo Adomi, Yoshitaka Saito, Saizo Fujimoto, Mitsuhisa Nishimoto, Takashi Kikuchi, Kazuhiro Yoshimura, Takafumi Minami, Masahiro Nozawa, Hirotsugu Uemura, Shunsuke Inoguchi, Mamoru Hashimoto, Kazuhiro Nose, Kazutoshi Fujita, Yasunori Mori
Publikováno v:
Anti-Cancer Drugs. 33:e818-e821
Recently, combination therapy including immune checkpoint inhibition (ICI) has proven to be effective as first-line therapy for patients with metastatic renal cell carcinoma. Although the first-line combination therapies with ICI have shown clinical
Autor:
Naoki Matsumura, Kazutoshi Fujita, Mitsuhisa Nishimoto, Takafumi Minami, Hideo Tahara, Kazuhiro Yoshimura, Hirotsugu Uemura
Publikováno v:
World Journal of Urology.
The therapeutic landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has changed dramatically. Here, we provide the current status and future prospective of the management of mHSPC.We reviewed recent literature of landmark studies on th